ZBP1 and colorectal carcinoma: To determine whether ZBP1-derived PANoptosis is activated by chemotherapy, we first examined dsRNA expression, as we showed it could be recognized by ZBP1 to trigger PANoptosis, in normal colonic tissues with/without oxaliplatin-based chemotherapy in CRC patients (Supplementary Table II).